You are here

swatic's blog

Clear Aligners Market Size $28.86 Billion by 2030

Submitted by swatic on Tue, 02/06/2024 - 19:49

Report Overview:

The Global Clear Aligners Market achieved a valuation of $3.86 Billion in 2022 and is anticipated to exceed $28.86 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 28.6% during the forecast period from 2024 to 2032.

Key Market Players:

Dentsply Sirona (US), 3M EPSE (US), Henry Schein Inc. (US), Patterson Companies Inc. (US), TP Orthodontics Inc. (US), Align Technology Inc. (US), Danaher Corporation Inc. (US), Dentsply International Inc. (US) and Straumann Group (Switzerland).

Medical Non-Woven Disposables Market Size $23260.95 Million by 2030

Submitted by swatic on Tue, 02/06/2024 - 19:49

Report Overview:

The Global Medical Non-Woven Disposables Market achieved a valuation of $19391.99 Million in 2022 and is anticipated to exceed $23260.95 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 2.3% during the forecast period from 2024 to 2032.

Key Market Players:

Ahlstrom Corporation, Kimberly-Clark Corporation, Unicharm Corporation, Dynarex Corporation, Freudenberg & Co. KG, Georgia-Pacific, INTCO Medical, MEDTRONIC, B. Braun, Cardinal Health, Swedish Cellulosa Aktiebolaget SCA, Domtar Corporation and others.

Connected Health Device Market Size $7.62 Billion by 2030

Submitted by swatic on Tue, 02/06/2024 - 19:48

Report Overview:

The Global Connected Health Device Market achieved a valuation of $1.25 Billion in 2022 and is anticipated to exceed $7.62 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 25.3% during the forecast period from 2024 to 2032.

Key Market Players:

GE Healthcare, Honeywell International Inc., Medtronic Inc., Abbott Laboratories, Koninklijke Philips NV are the major companies operating in Connected Medical Device Market.

Healthcare mobility solutions Market Size $266.91 Million by 2030

Submitted by swatic on Mon, 02/05/2024 - 19:52

Report Overview:

The Global Healthcare mobility solutions Market achieved a valuation of $78.12 Million in 2022 and is anticipated to exceed $266.91 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 16.6% during the forecast period from 2024 to 2032.

Key Market Players:

Oracle Corporation, AT&T, Inc, Cisco Systems, Inc., Philips Healthcare, SAP SE, Zebra Technologies Corporation, Cerner Corporation, Mckesson Corporation, Omron Corporation, and Airstrip Technologies, Inc.

Enteric Empty Capsules Market Size $223.37 Million by 2030

Submitted by swatic on Mon, 02/05/2024 - 19:52

Report Overview:

The Global Enteric Empty Capsules Market achieved a valuation of $74.56 Million in 2022 and is anticipated to exceed $223.37 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 14.7% during the forecast period from 2024 to 2032.

Key Market Players:

Capsugel (US), ACG Worldwide (India), Qualicaps (US), Suheung Co. Ltd. (Korea), CapsCanada Corporation (Canada), Qingdao Yiqing Medicinal Capsules Co., Ltd. (China), Shanxi Guangsheng Medicinal Capsules Co., Ltd. (China), Healthcaps India Ltd. (India).

Artificial Pancreas Device System Market Size $285.40 Million by 2030

Submitted by swatic on Mon, 02/05/2024 - 19:52

Report Overview:

The Global Artificial Pancreas Device System Market achieved a valuation of $107.35 Million in 2022 and is anticipated to exceed $285.40 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 13% during the forecast period from 2024 to 2032.

Key Market Players:

Medtronic Plc., Medtrum Technologies Inc., Tandem Diabetes Care, Inc., Johnson & Johnson, Beta Bionics, Inc., Bigfoot Biomedical, Insulet Corporation, Pancreum, Inc., TypeZero Technologies, Inc., DreaMed Diabetes Ltd, and Inreda Diabetic BV.

Artificial Pancreas Device System Market Size $285.40 Million by 2030

Submitted by swatic on Mon, 02/05/2024 - 19:52

Report Overview:

The Global Artificial Pancreas Device System Market achieved a valuation of $107.35 Million in 2022 and is anticipated to exceed $285.40 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 13% during the forecast period from 2024 to 2032.

Key Market Players:

Medtronic Plc., Medtrum Technologies Inc., Tandem Diabetes Care, Inc., Johnson & Johnson, Beta Bionics, Inc., Bigfoot Biomedical, Insulet Corporation, Pancreum, Inc., TypeZero Technologies, Inc., DreaMed Diabetes Ltd, and Inreda Diabetic BV.

Pages

Subscribe to RSS - swatic's blog